High-dose cyclophosphamide in aplastic anaemia [5] (multiple letters)

Lancet

Volumn 357, Issue 9262, 2001, Pages 1128-1129

  Brodsky, Robert A ^a   Jones, Richard J ^a   Tisdale, John F ^b   Young, Neal S ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NHLBI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; BLOOD CELL COUNT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MORBIDITY; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035820290     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04278-1     Document Type: Letter

References (5)

1. Tisdale JF Dunn DE Geller N High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial Lancet 356 2000 1554 1559
2. Socie G Henry-Amar M Bacigalupo A Malignant tumors occurring after treatment of aplastic anemia N Engl J Med 329 1993 1152 1157
3. Frickhofen N Rosenfeld SJ Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine Semin Hematol 37 2000 56 58
4. Doney K Leisenring W Storb R Appelbaum FR Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy Ann Intern Med 126 1997 107 115
5. Brodsky RA Sensenbrenner LL Jones RJ Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide Blood 87 1996 491 494